CLINICAL_TRIALS
trial_result
· 2012-05-21
Clinical Trial Update: Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA) [Phase 3]
Summary
This Phase 3 study evaluated the efficacy and safety of lumiracoxib in adults with primary knee osteoarthritis and has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED